Signals from randomized clinical trials predicting hepatotoxicity of flupirtine: systematic review.
Saved in:
| Title: | Signals from randomized clinical trials predicting hepatotoxicity of flupirtine: systematic review. |
|---|---|
| Authors: | Fidahic M; Agency for Quality and Accreditation in Healthcare in the FBIH, Sarajevo, Bosnia and Herzegovina., Lozo Vukovac E; Department of Pulmonary Diseases, University Hospital Split, Split, Croatia., Balkowiec-Iskra E; Department of Experimental and Clinical Pharmacology, Medical University of Warsaw, Warsaw, Poland.; The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products, Warsaw, Poland., Krnic D; pharmaand GmbH, Vienna, Austria., Andric A; NDA Regulatory Science Ltd., Leatherhead, UK., Margan Koletic Z; The Department for Pharmacovigilance and Rational Pharmacotherapy, Agency for Medicinal Products and Medical Devices of Croatia (HALMED), Zagreb, Croatia., Puljak L; Center for Evidence-Based Medicine and Health Care, Department of Nursing, School of Medicine, Catholic University of Croatia, Ilica 244, 10000, Zagreb, Croatia. livia.puljak@gmail.com. |
| Source: | European journal of clinical pharmacology [Eur J Clin Pharmacol] 2025 Jul; Vol. 81 (7), pp. 1043-1054. Date of Electronic Publication: 2025 Apr 23. |
| Publication Type: | Systematic Review; Journal Article |
| Journal Info: | Publisher: Springer Country of Publication: Germany NLM ID: 1256165 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1041 (Electronic) Linking ISSN: 00316970 NLM ISO Abbreviation: Eur J Clin Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
